Page last updated: 2024-08-25

picropodophyllin and Dysmyelopoietic Syndromes

picropodophyllin has been researched along with Dysmyelopoietic Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chang, C; Guo, J; He, Q; Li, X; Shi, W; Xu, F; Zhang, Z; Zhao, S; Zheng, Q	1

Other Studies

1 other study(ies) available for picropodophyllin and Dysmyelopoietic Syndromes

Article	Year
IGF‑IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway. Oncology reports, 2020, Volume: 44, Issue:3 Topics: Adolescent; Adult; Aged; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Computational Biology; Female; Gene Knockdown Techniques; Humans; K562 Cells; Male; MAP Kinase Signaling System; Middle Aged; Myelodysplastic Syndromes; Podophyllotoxin; Receptor, IGF Type 1; Transcriptome	2020

Article

Year

IGF‑IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway.

Oncology reports, 2020, Volume: 44, Issue:3

Topics: Adolescent; Adult; Aged; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Computational Biology; Female; Gene Knockdown Techniques; Humans; K562 Cells; Male; MAP Kinase Signaling System; Middle Aged; Myelodysplastic Syndromes; Podophyllotoxin; Receptor, IGF Type 1; Transcriptome

2020